EAM
RZLT icon

Exome Asset Management’s Rezolute RZLT Stock Holding History

Exome Asset Management’s Portfolio RZLT Stock Details RZLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-352,056
Closed -$1.71M – 76
2024
Q3 		$1.71M Buy
352,056
+69,656
+25% +$320K 1.15% 38
2024
Q2 		$1.21M Buy
+282,400
New +$970K 1.08% 35

Other funds holding RZLT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Exome Asset Management's RZLT Position: Q4 2024 in Review

Exome Asset Management sold out of Rezolute (RZLT) in Q4 2024, closing a stake of 352,056 shares — an estimated $1.71M sold.

Exome Asset Management first reported a position in RZLT in Q2 2024 and held it in 2 quarters. The position peaked at $1.71M in Q3 2024. 71 funds tracked by Wall St. Rank hold RZLT as of Q4 2024.

  • Exome Asset Management reported no remaining Rezolute position as of Q4 2024 after selling out during the quarter.
  • Exome Asset Management sold 352,056 Rezolute shares in Q4 2024, an estimated $1.71M.
  • Exome Asset Management first reported a position in Rezolute in Q2 2024 and held it in 2 quarters.
  • Exome Asset Management's Rezolute position peaked at $1.71M in Q3 2024.
  • 71 funds tracked by Wall St. Rank held Rezolute as of Q4 2024.

Based on Exome Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.